InvestorsHub Logo
icon url

steve butabi

08/21/07 10:42 PM

#16610 RE: mskatiescarletohara #16609

So katie

Humor me, what is your prediction for PPHM? Curtains? Or do you think Cotara will work (like I do) or that Bavi has a shot for cancer?

As far as HCV and SOC, I hear ya. I want to hear SK's explaination clear and precise as to why those trials have not started when in fact they said they'd do them a while ago. Its ok to question it but I wouldn't call it dead or a failure just yet. Too early to tell. "The cost to conduct HCV SOC trials have skyrocketed with the current competition."- Your quote. I think you answered you own question. Well, part of it at least.

And yes I know about all of the VEGF inhibtors but you mention the "craze" well 2c3 could've been caught up in that craze when it was hot but they chose to go wit hBavi instead. This is 3 and even 4 years ago. Both 3g4 and 2c3 were at equal stages 4 years ago. You bring the one out with the proven target first, especially since they are saying it is a unique inhibitor of VEGF. BP likes proven targets. VEGF is one. PS is not. Not yet, at least.



icon url

jakedogman1

08/22/07 7:41 AM

#16616 RE: mskatiescarletohara #16609

What is your agenda Katie? Are you now a paid basher? Are you trying to save us? What qualifies you to make your statements? Go back to Raging Bull.

Thx